These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16990634)

  • 1. Comparing two predictive methods for determining serum vancomycin concentrations at a Veterans Affairs Medical Center.
    Lee E; Winter ME; Boro MS
    Am J Health Syst Pharm; 2006 Oct; 63(19):1872-5. PubMed ID: 16990634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining vancomycin clearance in an overweight and obese population.
    Leong JV; Boro MS; Winter M
    Am J Health Syst Pharm; 2011 Apr; 68(7):599-603. PubMed ID: 21411801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin pharmacokinetics in middle-aged and elderly men.
    Leonard AE; Boro MS
    Am J Hosp Pharm; 1994 Mar; 51(6):798-800. PubMed ID: 8010319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive performance of a vancomycin-aminoglycoside population model.
    Beringer PM; Wong-Beringer A; Rho JP
    Ann Pharmacother; 1998 Feb; 32(2):176-81. PubMed ID: 9496400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of elevated trough serum vancomycin concentrations with obesity.
    Richardson J; Scheetz M; O'Donnell EP
    J Infect Chemother; 2015 Jul; 21(7):507-11. PubMed ID: 25851852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring of vancomycin in a morbidly obese patient.
    Penzak SR; Gubbins PO; Rodvold KA; Hickerson SL
    Ther Drug Monit; 1998 Jun; 20(3):261-5. PubMed ID: 9631922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictions of serum vancomycin concentrations by means of six different equations for calculation of creatinine clearance.
    Wu G; Furlanut M
    Int J Clin Pharmacol Res; 1997; 17(1):1-10. PubMed ID: 9403347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordance of Vancomycin Population-Predicted Pharmacokinetics with Patient-Specific Pharmacokinetics in Adult Hospitalized Patients: A Case Series.
    Onor IO; Neuliep A; Tran KA; Lambert J; Gillard CJ; Brakta F; Ezebuenyi MC; St James K; Okogbaa JI; Beyl RA
    Drugs R D; 2020 Jun; 20(2):83-93. PubMed ID: 32166646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictability of vancomycin trough concentrations using seven approaches for estimating pharmacokinetic parameters.
    Murphy JE; Gillespie DE; Bateman CV
    Am J Health Syst Pharm; 2006 Dec; 63(23):2365-70. PubMed ID: 17106010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of vancomycin in Thai patients.
    Purwonugroho TA; Chulavatnatol S; Preechagoon Y; Chindavijak B; Malathum K; Bunuparadah P
    ScientificWorldJournal; 2012; 2012():762649. PubMed ID: 22547995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight.
    Ducharme MP; Slaughter RL; Edwards DJ
    Ther Drug Monit; 1994 Oct; 16(5):513-8. PubMed ID: 7846752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of creatinine clearance estimation methods in patients with trauma.
    Davis GA; Chandler MH
    Am J Health Syst Pharm; 1996 May; 53(9):1028-32. PubMed ID: 8744465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cystatin C is a major predictor of vancomycin clearance in a population pharmacokinetic analysis of patients with normal serum creatinine concentrations.
    Chung JY; Jin SJ; Yoon JH; Song YG
    J Korean Med Sci; 2013 Jan; 28(1):48-54. PubMed ID: 23341711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Performance of Vancomycin Trough Concentrations in Patients With Diabetes With Microalbuminuria.
    Kimura H; Shigematsu M; Tanaka A; Watanabe S; Takatori S; Tanaka M; Mizuma T; Araki H
    Ther Drug Monit; 2017 Dec; 39(6):614-616. PubMed ID: 28976419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.
    Leader WG; Tsubaki T; Chandler MH
    Am J Hosp Pharm; 1994 Sep; 51(17):2125-30. PubMed ID: 7985687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of creatinine clearance in morbidly obese patients.
    Demirovic JA; Pai AB; Pai MP
    Am J Health Syst Pharm; 2009 Apr; 66(7):642-8. PubMed ID: 19299371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating aminoglycoside clearance and creatinine clearance in underweight patients.
    Khuu T; Bagdasarian G; Leung J; Nguyen N; Lam LD; Han EE; Ambrose PJ
    Am J Health Syst Pharm; 2010 Feb; 67(4):274-9. PubMed ID: 20133531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a pediatric population pharmacokinetic model for vancomycin.
    Hahn A; Frenck RW; Zou Y; Vinks AA
    Ther Drug Monit; 2015 Jun; 37(3):413-6. PubMed ID: 25423413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
    Horey A; Mergenhagen KA; Mattappallil A
    Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic parameters of vancomycin in critically ill patients.
    Llopis-Salvia P; Jiménez-Torres NV
    J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.